Form D · Biotechnology
Grobright Biotech Colorado, LLC
Denver, CO · CIK 0001784701
Offering snapshot reported Sep 9, 2019 · SEC filing
- Reported sold
- $600K Offering amount: $600K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 2, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 9, 2019 | Initial | $600,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $30K
- Form D file number
- 021-348247
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Ruben Mamann | None |
Source: Form D, filed Sep 9, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jake Davidson | Executive |
| David Drutz | Executive |
| David Stafford Johnson | Executive |
| Billy Morrison | Executive |
| Mark Tung | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
740 North Gilpin Street
Denver, CO, 80218
Denver, CO, 80218